Genetic factors may play an important role for HCV treatment response and disease progression in CHC [27], such as polymorphisms located around IL28B region that have been described as predictors of spontaneous HCV clearance and CHC treatment [28]. Here, IFNL3 is linked to cryohydrocytosis.